An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation

Figure 2

Frequency of incontinence episodes per week (n). Mean numbers of total incontinence episodes: baseline versus 6 months: ; baseline versus 12 months: ; and 6 versus 12 months: ; Wilcoxon rank test, data are presented as a mean ± SD.